By: Alanna Shaikh
2010 was an excellent year for progress against HIV – as long as you only look at the science side. Glance over at treatment and prevention and the news gets a lot more depressing. It’s been a year of big science breakthroughs and painful funding shortfalls on treatment and prevention. PEPFAR scaled down its ambitions and the Global Fund faces ugly gaps.
On the research side, we’ve had a really good year for HIV. We’ve seen some exciting news, especially in the last few months. We just found out last week that the same antiretrovirals which treat HIV will prevent it when taken by uninfected people. A clinical trial of 2,499 men found that proactively taking ARVs reduced HIV risk among participants by 43.8%. In July, scientists announced that they had discovered three powerful antibodies that can neutralize HIV; this could be a big step forward to an HIV vaccine and improving the effectiveness of ARV drugs.
Continue reading